Skip to main content
Erschienen in: Clinical Journal of Gastroenterology 3/2020

16.11.2019 | Case Report

An autopsy case of granulocyte colony-stimulating factor-producing pancreatic adenosquamous carcinoma

verfasst von: Noriko Inomata, Atsuhiro Masuda, Toshinao Itani, Motohito Hayashi, Yukari Shimada, Kanna Adachi, Kimio Hashimoto, Yasuhiro Tanaka, Atsushi Tanaka, Takashi Kobayashi, Arata Sakai, Hideyuki Shiomi, Yuzo Kodama

Erschienen in: Clinical Journal of Gastroenterology | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

A 60-year-old female was admitted to hospital with a continuous fever, a decreased appetite, and abdominal pain. Laboratory tests showed an elevated peripheral leukocyte count (13,800/μl) and increased C-reactive protein (19.1 mg/dl) and carbohydrate antigen 19–9 (4057 U/ml) levels. Abdominal contrast-enhanced computed tomography showed multiple bulky hypovascular nodules in the liver, swelling of the paraaortic lymph nodes, and a hypovascular mass (diameter 3.0 cm) in the pancreatic body. The serum concentrations of granulocyte colony-stimulating factor (G-CSF) and interleukin-6 were 172 pg/μl and 541 pg/µl, respectively. Liver biopsy specimens revealed an adenosquamous carcinoma, which was positively immunostained for G-CSF. We diagnosed the patient with G-CSF-producing pancreatic cancer with multiple metastases. Four courses of gemcitabine with dexamethasone and one course of nab-paclitaxel and gemcitabine were administered. Although the pancreatic tumor and paraaortic lymph node metastases decreased in size, the liver metastases continued to grow. The patient died 4 months after the diagnosis of pancreatic cancer. An autopsy resulted in the tumor being diagnosed as poorly differentiated adenosquamous pancreatic carcinoma, which was histopathologically G-CSF-positive. Although G-CSF-producing pancreatic adenosquamous carcinomas are extremely rare, they have been encountered more frequently in recent years. In such cases, chemotherapy combined with dexamethasone might be effective at temporarily improving the patient’s condition.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Asano S, Urabe A, Okabe T, et al. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood. 1977;49:845–52.CrossRefPubMed Asano S, Urabe A, Okabe T, et al. Demonstration of granulopoietic factor(s) in the plasma of nude mice transplanted with a human lung cancer and in the tumor tissue. Blood. 1977;49:845–52.CrossRefPubMed
2.
Zurück zum Zitat Ohwada S, Miyamoto Y, Fujii T, et al. Colony stimulating factor producing carcinoma of the pancreas-a case report. Gan No Rinsho. 1989;35:523–7.PubMed Ohwada S, Miyamoto Y, Fujii T, et al. Colony stimulating factor producing carcinoma of the pancreas-a case report. Gan No Rinsho. 1989;35:523–7.PubMed
3.
Zurück zum Zitat Joshita S, Nakazawa K, Sugiyama Y, et al. Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. Intern Med. 2009;48:687–91.CrossRefPubMed Joshita S, Nakazawa K, Sugiyama Y, et al. Granulocyte-colony stimulating factor-producing pancreatic adenosquamous carcinoma showing aggressive clinical course. Intern Med. 2009;48:687–91.CrossRefPubMed
4.
Zurück zum Zitat Takami K, Miura K, Takeuchi H, et al. Granulocyte-colony stimulating factor-producing pancreatic cancer: report of a case. Surg Today. 2008;38:453–7.CrossRefPubMed Takami K, Miura K, Takeuchi H, et al. Granulocyte-colony stimulating factor-producing pancreatic cancer: report of a case. Surg Today. 2008;38:453–7.CrossRefPubMed
5.
Zurück zum Zitat Gotohda N, Nakagohri T, Saito N, et al. A case of anaplastic ductal carcinoma of the pancreas with production of granulocyte-colony stimulating factor. Hepatogastroenterology. 2006;53:957–9.PubMed Gotohda N, Nakagohri T, Saito N, et al. A case of anaplastic ductal carcinoma of the pancreas with production of granulocyte-colony stimulating factor. Hepatogastroenterology. 2006;53:957–9.PubMed
6.
Zurück zum Zitat Fukushima N, Sasatomi E, Tokunaga O, et al. A case of pancreatic cancer with production of granulocyte colony-stimulating factor. Am J Gastroenterol. 2001;96:258–9.CrossRefPubMed Fukushima N, Sasatomi E, Tokunaga O, et al. A case of pancreatic cancer with production of granulocyte colony-stimulating factor. Am J Gastroenterol. 2001;96:258–9.CrossRefPubMed
7.
Zurück zum Zitat Yokoi H, Nakata M, Sawai K, et al. Intraglomerular metastasis from pancreatic cancer. Am J Kidney Dis. 2001;37:1299–303.CrossRefPubMed Yokoi H, Nakata M, Sawai K, et al. Intraglomerular metastasis from pancreatic cancer. Am J Kidney Dis. 2001;37:1299–303.CrossRefPubMed
8.
Zurück zum Zitat Ohtsubo K, Mouri H, Sakai J, et al. Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry. J Clin Gastroenterol. 1998;27:357–60.CrossRefPubMed Ohtsubo K, Mouri H, Sakai J, et al. Pancreatic cancer associated with granulocyte-colony stimulating factor production confirmed by immunohistochemistry. J Clin Gastroenterol. 1998;27:357–60.CrossRefPubMed
9.
Zurück zum Zitat Uematsu T, Tsuchie K, Ukai K, et al. Granulocyte-colony stimulating factor produced by pancreatic carcinoma. Int J Pancreatol. 1996;19:135–9.PubMed Uematsu T, Tsuchie K, Ukai K, et al. Granulocyte-colony stimulating factor produced by pancreatic carcinoma. Int J Pancreatol. 1996;19:135–9.PubMed
10.
Zurück zum Zitat Kataoka K, Achiwa K, Minami Y, et al. A case of a patient with granulocyte-colony stimulating factor-producing pancreatic cancer who responded to nab-paclitaxel plus gemcitabine. Nihon Shokakibyo Gakkai Zasshi. 2017;114(7):1277–84.PubMed Kataoka K, Achiwa K, Minami Y, et al. A case of a patient with granulocyte-colony stimulating factor-producing pancreatic cancer who responded to nab-paclitaxel plus gemcitabine. Nihon Shokakibyo Gakkai Zasshi. 2017;114(7):1277–84.PubMed
11.
Zurück zum Zitat Naruse H, Shimoyama N, Kudo T, et al. Autopsy of invasive ductal pancreatic carcinoma that transformed into a tumor producing granulocyte colony-stimulating factor. Nihon Shokakibyo Gakkai Zasshi. 2017;114(5):854–64.PubMed Naruse H, Shimoyama N, Kudo T, et al. Autopsy of invasive ductal pancreatic carcinoma that transformed into a tumor producing granulocyte colony-stimulating factor. Nihon Shokakibyo Gakkai Zasshi. 2017;114(5):854–64.PubMed
12.
Zurück zum Zitat Hayashi H, Eguchi N, Sumimoto K, et al. Autopsy of anaplastic carcinoma of the pancreas producing granulocyte colony-stimulating factor. Nihon Shokakibyo Gakkai Zasshi. 2016;113(8):1408–15.PubMed Hayashi H, Eguchi N, Sumimoto K, et al. Autopsy of anaplastic carcinoma of the pancreas producing granulocyte colony-stimulating factor. Nihon Shokakibyo Gakkai Zasshi. 2016;113(8):1408–15.PubMed
13.
Zurück zum Zitat Inoue Y, Koizumi M, Sata N, et al. A case of granulocyte-colony stimulating factor producing anaplastic carcinoma of the pancreas. Jpn J Gastroenterol Surg. 2012;45:427–33.CrossRef Inoue Y, Koizumi M, Sata N, et al. A case of granulocyte-colony stimulating factor producing anaplastic carcinoma of the pancreas. Jpn J Gastroenterol Surg. 2012;45:427–33.CrossRef
14.
Zurück zum Zitat Kudo M, Yamagata S, Shibahara Y, et al. A case of granulocyte colony-stimulating factor-producing anaplastic carcinoma of the pancreas. J Jpn Pancreas Soc. 2015;30:607–13.CrossRef Kudo M, Yamagata S, Shibahara Y, et al. A case of granulocyte colony-stimulating factor-producing anaplastic carcinoma of the pancreas. J Jpn Pancreas Soc. 2015;30:607–13.CrossRef
15.
Zurück zum Zitat Masuda S, Koizumi K, Nishino T, et al. A granulocyte colony-stimulating factor-producing pancreatic adenocarcinoma treated with nab-paclitaxel plus gemcitabine chemotherapy. J Jpn Pancreas Soc. 2018;33:768–75.CrossRef Masuda S, Koizumi K, Nishino T, et al. A granulocyte colony-stimulating factor-producing pancreatic adenocarcinoma treated with nab-paclitaxel plus gemcitabine chemotherapy. J Jpn Pancreas Soc. 2018;33:768–75.CrossRef
16.
Zurück zum Zitat Matsumoto I, Kainuma O, Yamamoto H, et al. Adenocarcinoma of pancreas with non-suppurative fever, producing granulocyte-colony stimulating factor: a case report and literature review. J Jpn Pancreas Soc. 2010;25:585–90.CrossRef Matsumoto I, Kainuma O, Yamamoto H, et al. Adenocarcinoma of pancreas with non-suppurative fever, producing granulocyte-colony stimulating factor: a case report and literature review. J Jpn Pancreas Soc. 2010;25:585–90.CrossRef
17.
Zurück zum Zitat Ikeda S, Okubo K, Shibahara H, et al. An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy. Gan To Kagaku Ryoho. 2013;40(6):789–92.PubMed Ikeda S, Okubo K, Shibahara H, et al. An autopsy of G-CSF-producing anaplastic carcinoma of the pancreas with impaired accumulation on FDG-PET after S-1 chemotherapy. Gan To Kagaku Ryoho. 2013;40(6):789–92.PubMed
18.
Zurück zum Zitat Suzuki A, Takahashi T, Okuno Y, et al. Liver damage in patients with colony-stimulating factor-producing tumors. Am J Med. 1993;94:125–32.CrossRefPubMed Suzuki A, Takahashi T, Okuno Y, et al. Liver damage in patients with colony-stimulating factor-producing tumors. Am J Med. 1993;94:125–32.CrossRefPubMed
19.
Zurück zum Zitat Charbit A, Malase EP, Tubiana M, et al. Relation between the pathlogical and the rate of human tumors. Eur J Cancer. 1971;7:307–17.CrossRefPubMed Charbit A, Malase EP, Tubiana M, et al. Relation between the pathlogical and the rate of human tumors. Eur J Cancer. 1971;7:307–17.CrossRefPubMed
Metadaten
Titel
An autopsy case of granulocyte colony-stimulating factor-producing pancreatic adenosquamous carcinoma
verfasst von
Noriko Inomata
Atsuhiro Masuda
Toshinao Itani
Motohito Hayashi
Yukari Shimada
Kanna Adachi
Kimio Hashimoto
Yasuhiro Tanaka
Atsushi Tanaka
Takashi Kobayashi
Arata Sakai
Hideyuki Shiomi
Yuzo Kodama
Publikationsdatum
16.11.2019
Verlag
Springer Singapore
Erschienen in
Clinical Journal of Gastroenterology / Ausgabe 3/2020
Print ISSN: 1865-7257
Elektronische ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-01067-6

Weitere Artikel der Ausgabe 3/2020

Clinical Journal of Gastroenterology 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Neuer Myosin-Inhibitor bei hypertropher Kardiomyopathie von Nutzen

17.05.2024 Kardiomyopathie Nachrichten

Mit Aficamten hat ein zweiter kardialer Myosin-Inhibitor seinen therapeutischen Nutzen bei symptomatischen Patienten mit obstruktiver hypertropher Kardiomyopathie (HCM) in einer randomisierten Phase-III-Studie klar unter Beweis gestellt.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.